Trial Profile
Bortezomib with Dexamethasone compared with oral melphalan and predonisone plus bortezomib in patients with refractory multiple myeloma: randomized phase 2 study
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone; Melphalan; Prednisone
- Indications Multiple myeloma
- Focus Therapeutic Use
- Acronyms TOMATO
- 23 Oct 2012 New trial record